• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑血管病死亡率的有效性

Validity of cerebrovascular mortality rates.

作者信息

Stehbens W E

机构信息

Department of Pathology, Wellington School of Medicine, New Zealand.

出版信息

Angiology. 1991 Apr;42(4):261-7. doi: 10.1177/000331979104200401.

DOI:10.1177/000331979104200401
PMID:2014916
Abstract

Cerebrovascular disease (CVD) mortality rates are being increasingly used to establish a relationship with coronary heart disease risk factors. Cerebrovascular mortality rates suffer from the same general defects as coronary heart disease mortality rates but with greater diagnostic error in regard to subdivisions of CVD or stroke. These vital statistics, whether national or regional, are too inaccurate for scientific use and cannot be regarded as representing true mortality rates for any country. Moreover, clinical CVD is an inappropriate surrogate for severity of atherosclerosis, providing inexact data and allowing indeterminate overlap in epidemiologic studies.

摘要

脑血管疾病(CVD)死亡率越来越多地被用于建立与冠心病危险因素的关系。脑血管疾病死亡率与冠心病死亡率存在相同的普遍缺陷,但在CVD或中风的细分方面存在更大的诊断误差。这些生命统计数据,无论是国家层面还是地区层面的,都不够准确,无法用于科学研究,也不能被视为代表任何国家的真实死亡率。此外,临床CVD并不是动脉粥样硬化严重程度的合适替代指标,它提供的数据不准确,并且在流行病学研究中存在不确定的重叠。

相似文献

1
Validity of cerebrovascular mortality rates.脑血管病死亡率的有效性
Angiology. 1991 Apr;42(4):261-7. doi: 10.1177/000331979104200401.
2
Review of the validity of national coronary heart disease mortality rates.
Angiology. 1990 Feb;41(2):85-94. doi: 10.1177/000331979004100201.
3
Coronary heart disease and cerebrovascular disease mortality in young adults: recent trends in Europe.年轻成年人的冠心病和脑血管疾病死亡率:欧洲近期趋势
Eur J Cardiovasc Prev Rehabil. 2011 Aug;18(4):627-34. doi: 10.1177/1741826710389393. Epub 2011 Apr 26.
4
Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update.欧洲及世界其他地区心血管疾病和脑血管疾病死亡率:最新情况
Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):333-50. doi: 10.1097/HJR.0b013e328325d67d.
5
Seasonal, regional and secular variations of cardiovascular and cerebrovascular mortality in New Zealand.新西兰心血管和脑血管死亡率的季节性、地区性及长期变化
Aust N Z J Med. 1990 Oct;20(5):669-76. doi: 10.1111/j.1445-5994.1990.tb00397.x.
6
Risk factors for cardiorespiratory and all cause mortality in men and women in urban Scotland: 15 year follow up.苏格兰城市地区男性和女性心肺及全因死亡率的危险因素:15年随访研究
Scott Med J. 1995 Aug;40(4):108-12. doi: 10.1177/003693309504000403.
7
Antioxidant status, erythrocyte fatty acids, and mortality from cardiovascular disease and Keshan disease in China.中国的抗氧化状态、红细胞脂肪酸与心血管疾病及克山病死亡率
Eur J Clin Nutr. 1994 Jul;48(7):455-64.
8
Cardiovascular mortality in a community: methodology and objective diagnostic criteria.社区中的心血管疾病死亡率:方法与客观诊断标准
Am J Epidemiol. 1971 Dec;94(6):531-45. doi: 10.1093/oxfordjournals.aje.a121352.
9
[Epidemiologic characteristics of cerebrovascular disease mortality in China, 2004-2005].[2004 - 2005年中国脑血管病死亡率的流行病学特征]
Zhonghua Yu Fang Yi Xue Za Zhi. 2010 Apr;44(4):293-7.
10
Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: results from 1-year outcomes in the Japanese REACH Registry.脑血管病和其他血管部位动脉粥样硬化血栓形成患者的心血管事件发生率:日本 REACH 登记研究 1 年结果。
J Neurol Sci. 2009 Dec 15;287(1-2):45-51. doi: 10.1016/j.jns.2009.09.011. Epub 2009 Oct 7.

引用本文的文献

1
Diagnostic validity of fatal cerebral strokes and coronary deaths in mortality statistics: an autopsy study.死亡统计中致命性脑卒中和冠心病死亡的诊断准确性:一项尸检研究。
Eur J Epidemiol. 2011 Mar;26(3):221-8. doi: 10.1007/s10654-010-9535-4. Epub 2010 Dec 18.
2
Science, atherosclerosis and the "age of unreason": a review.科学、动脉粥样硬化与“非理性时代”:综述
Integr Physiol Behav Sci. 1993 Oct-Dec;28(4):388-95. doi: 10.1007/BF02690936.